| P50 | author | Katharine K Miller | Q58399789 |
| | Sonja Schrepfer | Q88438770 |
| P2093 | author name string | Dong Wang | |
| | Hermann Reichenspurner | |
| | Daniel Bernstein | |
| | Joachim Velden | |
| | Xiaomeng Hu | |
| | Evgenios Neofytou | |
| | Tobias Deuse | |
| | Thomas Renne | |
| | Xiaoqin Hua | |
| P2860 | cites work | Drug Therapy in the Heart Transplant Recipient: Part I: Cardiac Rejection and Immunosuppressive Drugs | Q22306392 |
| | Cardiac allograft vasculopathy: current knowledge and future direction | Q33860323 |
| | Antitumor activity of thalidomide in refractory multiple myeloma | Q33880642 |
| | Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia | Q34021937 |
| | Potential novel uses of thalidomide: focus on palliative care | Q34030108 |
| | Thalidomide: A review of approved and investigational uses | Q35128432 |
| | Heart retransplantation | Q36886336 |
| | Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. | Q36907896 |
| | Cardiac allograft vasculopathy: recent developments | Q37143722 |
| | Mechanisms of chronic cardiac allograft rejection | Q37197706 |
| | Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy | Q41069561 |
| | Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits | Q44934255 |
| | ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant | Q45101036 |
| | Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model | Q46182422 |
| | Serum matrix metalloprotease-1 and vascular endothelial growth factor--a predict cardiac allograft rejection. | Q46207648 |
| | Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778. | Q46687445 |
| | Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545. | Q54484449 |
| | Thalidomide | Q56091164 |
| | IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model | Q57273010 |
| | Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation | Q69910910 |
| | Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis | Q70150078 |
| | Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates | Q73848236 |
| | THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS | Q78373559 |
| | Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease | Q79892571 |
| | Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits | Q80502381 |
| | Thalidomide attenuates graft arteriosclerosis of aortic transplant in a rat model | Q84409985 |
| | Effect of adiponectin on cardiac allograft vasculopathy | Q84520211 |
| P433 | issue | 11 | |
| P921 | main subject | thalidomide | Q203174 |
| P304 | page(s) | 1181-1189 | |
| P577 | publication date | 2017-08-14 | |
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study | |
| P478 | volume | 30 | |